JP2024525044A5 - - Google Patents

Info

Publication number
JP2024525044A5
JP2024525044A5 JP2023580802A JP2023580802A JP2024525044A5 JP 2024525044 A5 JP2024525044 A5 JP 2024525044A5 JP 2023580802 A JP2023580802 A JP 2023580802A JP 2023580802 A JP2023580802 A JP 2023580802A JP 2024525044 A5 JP2024525044 A5 JP 2024525044A5
Authority
JP
Japan
Prior art keywords
methyl
imidazo
triazine
carbonyl
carboxamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023580802A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024525044A (ja
Filing date
Publication date
Priority claimed from GBGB2109520.3A external-priority patent/GB202109520D0/en
Priority claimed from GBGB2203876.4A external-priority patent/GB202203876D0/en
Application filed filed Critical
Priority claimed from PCT/EP2022/068165 external-priority patent/WO2023275301A1/en
Publication of JP2024525044A publication Critical patent/JP2024525044A/ja
Publication of JP2024525044A5 publication Critical patent/JP2024525044A5/ja
Pending legal-status Critical Current

Links

JP2023580802A 2021-07-01 2022-06-30 Il-17モジュレータとしてのイミダゾトリアジン誘導体 Pending JP2024525044A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB2109520.3 2021-07-01
GBGB2109520.3A GB202109520D0 (en) 2021-07-01 2021-07-01 Therapeutic agents
GBGB2203876.4A GB202203876D0 (en) 2022-03-21 2022-03-21 Therapeutic agents
GB2203876.4 2022-03-21
PCT/EP2022/068165 WO2023275301A1 (en) 2021-07-01 2022-06-30 Imidazotriazine derivatives as il-17 modulators

Publications (2)

Publication Number Publication Date
JP2024525044A JP2024525044A (ja) 2024-07-09
JP2024525044A5 true JP2024525044A5 (cg-RX-API-DMAC7.html) 2025-06-25

Family

ID=82493962

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023580802A Pending JP2024525044A (ja) 2021-07-01 2022-06-30 Il-17モジュレータとしてのイミダゾトリアジン誘導体

Country Status (6)

Country Link
US (1) US20240294534A1 (cg-RX-API-DMAC7.html)
EP (1) EP4363421A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024525044A (cg-RX-API-DMAC7.html)
AR (1) AR126255A1 (cg-RX-API-DMAC7.html)
TW (1) TW202317576A (cg-RX-API-DMAC7.html)
WO (1) WO2023275301A1 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201909190D0 (en) * 2019-06-26 2019-08-07 Ucb Biopharma Sprl Therapeutic agents
GB202210731D0 (en) 2022-07-22 2022-09-07 UCB Biopharma SRL Therapeutic agents
TW202430165A (zh) 2022-12-02 2024-08-01 丹麥商理奧藥品公司 Il-17之小分子調節劑
WO2024126249A1 (en) 2022-12-14 2024-06-20 UCB Biopharma SRL Imidazotriazine derivatives as il-17 modulators
GB202218860D0 (en) 2022-12-14 2023-01-25 Ucb Biopharma Sprl Therapeutic agents
GB202218846D0 (en) 2022-12-14 2023-01-25 UCB Biopharma SRL Therapeutic agents
KR20250145089A (ko) * 2023-02-13 2025-10-13 다이스 알파, 인크. 이미다조트리아진 il-17a 조정제 및 그의 용도
EP4688156A1 (en) * 2023-03-28 2026-02-11 Janssen Pharmaceutica NV Lactam-containing imidazopyridazine il-17 inhibitor compounds
GB202305587D0 (en) 2023-04-17 2023-05-31 UCB Biopharma SRL Therapeutic agents
GB202305585D0 (en) 2023-04-17 2023-05-31 UCB Biopharma SRL Therapeutic agents
CN117551093B (zh) * 2023-11-14 2024-06-18 山东天锐医药科技有限公司 马来酸阿伐曲泊帕起始原料4-(4-氯-2-噻吩基)-2-噻唑胺的制备方法
WO2026012492A1 (en) * 2024-07-12 2026-01-15 Anew Therapeutics Pte. Ltd. Heterocyclic compounds as il-17 inhibitors
WO2026039171A1 (en) * 2024-08-12 2026-02-19 Dice Alpha, Inc. Il-17a inhibitors
WO2026039167A1 (en) * 2024-08-12 2026-02-19 Dice Alpha, Inc. Il-17a inhibitors
WO2026039168A1 (en) * 2024-08-12 2026-02-19 Dice Alpha, Inc. Il-17a inhibitors
WO2026039170A1 (en) * 2024-08-12 2026-02-19 Dice Alpha, Inc. Il-17a inhibitors
WO2026039172A1 (en) * 2024-08-12 2026-02-19 Dice Alpha, Inc. Il-17a inhibitors
WO2026073937A1 (en) 2024-10-02 2026-04-09 UCB Biopharma SRL Imidazotriazine derivatives as il-17 modulators
WO2026073929A1 (en) 2024-10-02 2026-04-09 UCB Biopharma SRL Imidazotriazine derivatives as il-17 modulators
WO2026073936A1 (en) 2024-10-02 2026-04-09 UCB Biopharma SRL Imidazotriazine derivatives as il-17 modulators

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2711696C (en) 2008-01-09 2021-10-26 Reza Dana Therapeutic compositions for treatment of ocular inflammatory disorders
EP2809660B1 (en) 2012-02-02 2016-01-20 Ensemble Therapeutics Corporation Macrocyclic compounds for modulating il-17
WO2014066726A2 (en) 2012-10-26 2014-05-01 Ensemble Therapeutics Corporation Compounds for modulating il-17
JP2020516440A (ja) 2016-11-22 2020-06-11 ヘパトケム,インコーポレイテッド 光化学デバイス
GB201709456D0 (en) 2017-06-14 2017-07-26 Ucb Biopharma Sprl Therapeutic agents
CN111601799B (zh) 2018-01-15 2023-06-09 Ucb生物制药有限责任公司 作为Il-17调节剂的稠合咪唑衍生物
WO2019223718A1 (zh) 2018-05-22 2019-11-28 成都先导药物开发股份有限公司 一种免疫调节剂
WO2020011731A1 (en) 2018-07-12 2020-01-16 UCB Biopharma SRL Spirocyclic indane analogues as il-17 modulators
GB201820165D0 (en) 2018-12-11 2019-01-23 Ucb Biopharma Sprl Therapeutic agents
GB201820166D0 (en) 2018-12-11 2019-01-23 Ucb Biopharma Sprl Therapeutic agents
MX2021006421A (es) 2018-12-19 2021-08-16 Leo Pharma As Anilidas de aminoácidos como moduladores de moléculas pequeñas de interleucinas-17 (il-17).
TWI752400B (zh) 2019-01-07 2022-01-11 美商美國禮來大藥廠 Il-17a抑制劑
EP3935051A1 (en) 2019-03-08 2022-01-12 Leo Pharma A/S Small molecule modulators of il-17
GB201909194D0 (en) 2019-06-26 2019-08-07 Ucb Biopharma Sprl Therapeutic agents
GB201909190D0 (en) * 2019-06-26 2019-08-07 Ucb Biopharma Sprl Therapeutic agents
GB201909191D0 (en) 2019-06-26 2019-08-07 Ucb Biopharma Sprl Therapeutic agents
CN112341439B (zh) 2019-08-09 2022-02-15 成都先导药物开发股份有限公司 一种免疫调节剂
WO2021027722A1 (zh) 2019-08-09 2021-02-18 成都先导药物开发股份有限公司 一种免疫调节剂
WO2021027721A1 (zh) 2019-08-09 2021-02-18 成都先导药物开发股份有限公司 一种免疫调节剂
WO2021027729A1 (zh) 2019-08-09 2021-02-18 成都先导药物开发股份有限公司 一种免疫调节剂
WO2021098844A1 (zh) 2019-11-20 2021-05-27 成都先导药物开发股份有限公司 一种免疫调节剂
WO2021170631A1 (en) 2020-02-25 2021-09-02 UCB Biopharma SRL Difluorocyclohexyl derivatives as il-17 modulators
WO2021170627A1 (en) 2020-02-25 2021-09-02 UCB Biopharma SRL Difluorocyclohexyl derivatives as il-17 modulators
CN115702024A (zh) 2020-04-07 2023-02-14 Ucb生物制药有限责任公司 用作il-17调节剂的二氟环己基衍生物
WO2021204800A1 (en) 2020-04-07 2021-10-14 UCB Biopharma SRL Difluorocyclohexyl derivatives as il-17 modulators
WO2022096411A1 (en) 2020-11-09 2022-05-12 UCB Biopharma SRL Dicyclopropylmethyl derivatives as il-17 modulators
WO2022096412A1 (en) 2020-11-09 2022-05-12 UCB Biopharma SRL Dicyclopropylmethyl derivatives as il-17 modulators
US20240140951A1 (en) 2020-12-14 2024-05-02 UCB Biopharma SRL Imidazopyridazine derivatives as il-17 modulators

Similar Documents

Publication Publication Date Title
JP2023552864A5 (cg-RX-API-DMAC7.html)
USRE49594E1 (en) Apelin receptor (APJ) agonists and uses thereof
EP2590981B1 (en) Novel homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof
MX2014008279A (es) Compuestos de carbamato y preparacion y uso de los mismos.
CA2529443A1 (en) Pyrido[2,1-a]-isoquinoline derivatives as dpp-iv inhibitors
RU2637938C2 (ru) Производные триазолкарбоксамида
AU2013314388B2 (en) Pyrazole carboxamide derivatives as TAAR modulators for use in the treatment of several disorders, such as depression, diabetes and Parkinson's disease
SG193556A1 (en) Heterocyclic amine derivatives
JP2002356471A (ja) 脂肪族含窒素五員環化合物
JP7854780B2 (ja) 核内受容体に対して活性の化合物
NL1028193C2 (nl) Farmaceutisch werkzame verbindingen.
WO2016030310A1 (en) Substituted azetidine derivatives as taar ligands
JP2019521167A5 (cg-RX-API-DMAC7.html)
HRP20241015T1 (hr) Derivati aminopiridina i njihova uporaba kao selektivnih alk-2 inhibitora
RU2014123784A (ru) Новые производные пирролидина в качестве ингибиторов катепсина
CA2784007C (en) Pyrrolidine derivatives
JP5389917B2 (ja) ケモカインレセプターのジアゼパン及びピペラジン誘導体モデュレーター
EP3137459A1 (en) Morpholin-pyridine derivatives
RU2587512C2 (ru) Производные дигидрооксазол-2-амина
CA2449578A1 (en) Pyrrolidine oxadiazole- and thiadiazole derivatives
EP3008055B1 (en) Tetrazolone derivatives
RU2013135176A (ru) Производные пиролидина в качестве антагонистов nk3
WO2019022235A1 (ja) 円形脱毛症の治療剤又は予防剤
JP2019508390A (ja) mGluR7調節薬としてのインダン誘導体
JP2015157764A (ja) グリシントランスポーター阻害物質